Abstract:The identification of drug/compound–target interactions (DTIs) constitutes the basis of drug discovery, for which computational predictive approaches have been developed. As a relatively new data-driven paradigm, proteochemometric (PCM) modeling utilizes both protein and compound properties as a pair at the input level and processes them via statistical/machine learning. The representation of input samples (i.e., proteins and their ligands) in the form of quantitative feature vectors is crucial for the extraction of interaction-related properties during the artificial learning and subsequent prediction of DTIs. Lately, the representation learning approach, in which input samples are automatically featurized via training and applying a machine/deep learning model, has been utilized in biomedical sciences. In this study, we performed a comprehensive investigation of different computational approaches/techniques for protein featurization (including both conventional approaches and the novel learned embeddings), data preparation and exploration, machine learning-based modeling, and performance evaluation with the aim of achieving better data representations and more successful learning in DTI prediction. For this, we first constructed realistic and challenging benchmark datasets on small, medium, and large scales to be used as reliable gold standards for specific DTI modeling tasks. We developed and applied a network analysis-based splitting strategy to divide datasets into structurally different training and test folds. Using these datasets together with various featurization methods, we trained and tested DTI prediction models and evaluated their performance from different angles. Our main findings can be summarized under 3 items: (i) random splitting of datasets into train and test folds leads to near-complete data memorization and produce highly over-optimistic results, as a result, should be avoided, (ii) learned protein sequence embeddings work well in DTI prediction and offer high potential, despite interaction-related properties (e.g., structures) of proteins are unused during their self-supervised model training, and (iii) during the learning process, PCM models tend to rely heavily on compound features while partially ignoring protein features, primarily due to the inherent bias in DTI data, indicating the requirement for new and unbiased datasets. We hope this study will aid researchers in designing robust and high-performing data-driven DTI prediction systems that have real-world translational value in drug discovery.

Machine learning approaches for predicting compounds that interact with therapeutic and ADMET related proteins.

Advances In Machine Learning Prediction Of Toxicological Properties And Adverse Drug Reactions Of Pharmaceutical Agents

Machine Learning for Sequence and Structure-Based Protein–Ligand Interaction Prediction

Statistical Learning Approach for Predicting Specific Pharmacodynamic, Pharmacokinetic, or Toxicological Properties of Pharmaceutical Agents

Prediction of compounds with specific pharmacodynamic, pharmacokinetic or toxicological property by statistical learning methods.

PharML.Bind: Pharmacologic Machine Learning for Protein-Ligand Interactions

Application of Machine Learning for Drug–Target Interaction Prediction

A Review of Approaches for Predicting Drug–Drug Interactions Based on Machine Learning

How to approach machine learning-based prediction of drug/compound–target interactions

On Machine Learning Approaches for Protein-Ligand Binding Affinity Prediction

Recent Progresses in the Exploration of Machine Learning Methods As In-Silico ADME Prediction Tools

Drug-target Interaction Prediction: Databases, Web Servers and Computational Models.

Machine Learning Approaches and their Applications in Drug Discovery and Design

Comparative analysis of machine learning methods in ligand-based virtual screening of large compound libraries.

Leveraging Machine Learning Models for Peptide-Protein Interaction Prediction

Machine Learning Prediction of On/Off Target-driven Clinical Adverse Events

Binding Affinity Prediction: From Conventional to Machine Learning-Based Approaches

Machine Learning Small Molecule Properties in Drug Discovery

Modern machine‐learning for binding affinity estimation of protein–ligand complexes: Progress, opportunities, and challenges

Similarity-based machine learning methods for predicting drug-target interactions: a brief review.

A Novel Strategy for Prediction of Human Plasma Protein Binding Using Machine Learning Techniques